{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:25:57Z","timestamp":1790630757421,"version":"4.1.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Int Soc Prevent Communit Dent"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/2231-0762.178742","type":"journal-article","created":{"date-parts":[[2016,3,16]],"date-time":"2016-03-16T00:40:17Z","timestamp":1458088817000},"page":"97","source":"Crossref","is-referenced-by-count":154,"title":["Medication-related osteonecrosis of the jaw: Clinical and practical guidelines"],"prefix":"10.4103","volume":"6","author":[{"given":"Piero","family":"Papi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Rosella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Giardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emauele","family":"Cicalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Piccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Pompa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2231-0762.178742-1","first-page":"1938","volume-title":"American Association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw \u2013 2014 update","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"key-10.4103\/2231-0762.178742-2","first-page":"2","volume-title":"American Association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaws \u2013 2009 update","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"key-10.4103\/2231-0762.178742-3","first-page":"297","volume-title":"Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: Comparison of 30-, 60-, and 90-mg dosages","author":"Nussbaum","year":"1993","journal-title":"Am J Med"},{"key":"key-10.4103\/2231-0762.178742-4","first-page":"2038","volume-title":"Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate.Protocol 19 Aredia Breast Cancer Study Group","author":"Hortobagyi","year":"1998","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/2231-0762.178742-5","first-page":"879","volume-title":"Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer","author":"Saad","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"key-10.4103\/2231-0762.178742-6","first-page":"3719","volume-title":"American society of clinical oncology clinical practice guidelines: The role of bisphosphonates in multiple myeloma","author":"Berenson","year":"2002","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/2231-0762.178742-7","first-page":"462","volume-title":"The use of bisphosphonates in the treatment of osteoporosis","author":"Delmas","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"key-10.4103\/2231-0762.178742-8","unstructured":"Medical economics. Physicians' Desk Reference. 57th ed. Montvale, NJ: Medical Economics; 2003."},{"key":"key-10.4103\/2231-0762.178742-9","first-page":"558","volume-title":"The management of Paget's disease of bone","author":"Delmas","year":"1997","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2231-0762.178742-10","first-page":"325","volume-title":"Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases","author":"Delmas","year":"2008","journal-title":"J Clin Densitom"},{"key":"key-10.4103\/2231-0762.178742-11","first-page":"813","volume-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: A randomised, double-blind study","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"key-10.4103\/2231-0762.178742-12","first-page":"147","volume-title":"Medication-Related Osteonecrosis of the Jaws (MRONJ): Etiological update","author":"Tenore","year":"2014","journal-title":"Senses Sci"},{"key":"key-10.4103\/2231-0762.178742-13","first-page":"318","volume-title":"Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?","author":"Reid","year":"2007","journal-title":"Bone"},{"key":"key-10.4103\/2231-0762.178742-14","first-page":"61","volume-title":"The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: So many hypotheses, so few data","author":"Allen","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"key-10.4103\/2231-0762.178742-15","first-page":"8580","volume-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors","author":"Bamias","year":"2005","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/2231-0762.178742-16","first-page":"433","volume-title":"Bisphosphonate-related osteonecrosis of the jaw: Background and guidelines for diagnosis, staging and management","author":"Ruggiero","year":"2006","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"key-10.4103\/2231-0762.178742-17","first-page":"1010","volume-title":"Pamidronate enhances bacterial adhesion to bone hydroxyapatite.Another puzzle in the pathology of bisphosphonate-related osteonecrosis of the jaw?","author":"Kos","year":"2013","journal-title":"J Oral Maxillofac Surg"},{"key":"key-10.4103\/2231-0762.178742-18","first-page":"403","volume-title":"Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: A meta-analysis of seven randomized controlled trials","author":"Qi","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"key-10.4103\/2231-0762.178742-19","first-page":"1823","volume-title":"Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: Subgroup analysis from a randomized phase 3 study","author":"Scagliotti","year":"2012","journal-title":"J Thorac Oncol"},{"key":"key-10.4103\/2231-0762.178742-20","first-page":"5356","volume-title":"Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw","author":"Vahtsevanos","year":"2009","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/2231-0762.178742-21","first-page":"1365","volume-title":"The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: Data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program","author":"Grbic","year":"2010","journal-title":"J Am Dent Assoc"},{"key":"key-10.4103\/2231-0762.178742-22","first-page":"694","volume-title":"Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension","author":"Papapoulos","year":"2012","journal-title":"J Bone Miner Res"},{"key":"key-10.4103\/2231-0762.178742-23","first-page":"243","volume-title":"Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure","author":"Lo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"key-10.4103\/2231-0762.178742-24","first-page":"433","volume-title":"Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: A meta-analysis","author":"Mauri","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"key-10.4103\/2231-0762.178742-25","first-page":"403","volume-title":"Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: A meta-analysis of seven randomized controlled trials","author":"Qi","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"key-10.4103\/2231-0762.178742-26","first-page":"429","volume-title":"Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II\/III breast cancer","author":"Coleman","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"key-10.4103\/2231-0762.178742-27","first-page":"181","volume-title":"Bevacizumab and osteonecrosis of the jaw: Incidence and association with bisphosphonate therapy in three large prospective trials in advanced breast cancer","author":"Guarneri","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"key-10.4103\/2231-0762.178742-28","first-page":"1341","volume-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: Integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","author":"Saad","year":"2012","journal-title":"Ann Oncol"},{"key":"key-10.4103\/2231-0762.178742-29","first-page":"1397","volume-title":"Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: A cohort study","author":"Yamazaki","year":"2012","journal-title":"Int J Oral Maxillofac Surg"},{"key":"key-10.4103\/2231-0762.178742-30","first-page":"621","volume-title":"Learning from experience.Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ)","author":"Bedogni","year":"2012","journal-title":"Oral Dis"},{"key":"key-10.4103\/2231-0762.178742-31","first-page":"13","volume-title":"Up to a quarter of patients with osteonecrosis of the jaw associated with antiresorptive agents remain undiagnosed","author":"Fedele","year":"2015","journal-title":"Br J Oral Maxillofac Surg"},{"key":"key-10.4103\/2231-0762.178742-32","unstructured":"Marx RE. Oral and Intravenous Bisphosphonate-Induced Osteonecrosis of the Jaw. Chicago, Ill, USA: Quintessence; 2007."},{"key":"key-10.4103\/2231-0762.178742-33","first-page":"117","volume-title":"Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid","author":"Dimopoulos","year":"2009","journal-title":"Ann Oncol"},{"key":"key-10.4103\/2231-0762.178742-34","first-page":"137","volume-title":"Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates.The experience of the National Cancer Institute of Milan","author":"Ripamonti","year":"2009","journal-title":"Ann Oncol"},{"key":"key-10.4103\/2231-0762.178742-35","first-page":"193","volume-title":"Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: A single-center clinical experience","author":"Vandone","year":"2012","journal-title":"Ann Oncol"},{"key":"key-10.4103\/2231-0762.178742-36","first-page":"33","volume-title":"Bisphosphonate-related osteonecrosis of the jaws: A potential alternative to drug holidays","author":"Damm","year":"2013","journal-title":"Gen Dent"},{"key":"key-10.4103\/2231-0762.178742-37","first-page":"1243","volume-title":"Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: Executive summary of recommendations from the American Dental Association Council on Scientific Affairs","author":"Hellstein","year":"2011","journal-title":"J Am Dent Assoc"},{"key":"key-10.4103\/2231-0762.178742-38","first-page":"1567","volume-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"key-10.4103\/2231-0762.178742-39","unstructured":"American Association of Endodontists. Endodontic Implication of Bisphosphonate-Associated Osteonecrosis of the Jaws. Chicago, IL: American Association of Endodontists; 2010. p. 4."},{"key":"key-10.4103\/2231-0762.178742-40","first-page":"179","volume-title":"Effect of low-level laser irradiation on bisphosphonate-induced osteonecrosis of the jaws: Preliminary results of a prospective study","author":"Scoletta","year":"2010","journal-title":"Photomed Laser Surg"},{"key":"key-10.4103\/2231-0762.178742-41","first-page":"447","volume-title":"Observation of pain control in patients with bisphosphonate-induced osteonecrosis using low level laser therapy: Preliminary results","author":"Romeo","year":"2011","journal-title":"Photomed Laser Surg"},{"key":"key-10.4103\/2231-0762.178742-42","first-page":"1329","volume-title":"Stage-related treatment concept of medication-related osteonecrosis of the jaw-a case series","author":"Rugani","year":"2015","journal-title":"Clin Oral Investig"},{"key":"key-10.4103\/2231-0762.178742-43","first-page":"85","volume-title":"The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws","author":"Carlson","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"key-10.4103\/2231-0762.178742-44","first-page":"631","volume-title":"Evaluation of highly porous dental implants in postablative oral and maxillofacial cancer patients: A prospective pilot clinical case series report","author":"Brauner","year":"2015","journal-title":"Implant Dent"},{"key":"key-10.4103\/2231-0762.178742-45","first-page":"2165","volume-title":"Outcomes of vascularized bone graft reconstruction of the mandible in bisphosphonate-related osteonecrosis of the jaws","author":"Seth","year":"2010","journal-title":"Laryngoscope"},{"key":"key-10.4103\/2231-0762.178742-46","first-page":"11","volume-title":"Bisphosphonates and Osteonecrosis of the jaw: The oral surgeon's perspective","author":"Pompa","year":"2012","journal-title":"Eur J Inflamm"}],"container-title":["Journal of International Society of Preventive and Community Dentistry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:26:15Z","timestamp":1786713975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/2231-0762.178742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"alternative-id":["178742"],"URL":"https:\/\/doi.org\/10.4103\/2231-0762.178742","relation":{},"ISSN":["2231-0762"],"issn-type":[{"value":"2231-0762","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}